In 272 resected colorectal cancers, dMMR/MSI-H was present in 9.6% of tumors and independently associated with younger age, proximal tumor location, and poor differentiation. (Clinical Therapeutics)
Molecular profiling study identifies clinicopathological factors linked to dMMR/MSI-H status
The CRC Digest